About me
Jean Y. Park, MD is an endocrinologist at MedStar Good Samaritan Hospital and a practicing physician with MedStar Health Primary Care at MedStar Good Samaritan since 2007. Dr. Park has a special interest in treating diabetes, thyroid disorders, adrenal disorders and pituitary diseases of patients 18 years of age and older.
Dr. Park has been awarded Recognition by the National Committee for Quality Assurance and American Diabetes Association Diabetes Recognition Program (DRP). Clinicians who achieve DRP Recognition are part of an elite group that is publicly recognized for its skill in providing the highest level of diabetes care.
Dr. Park has a role in clinical and research aspects of diabetes, diabetes related conditions, obesity and prediabetes. Her research focuses on optimal treatments for diabetes and prediabetes.
Clinical areas of focus
- Hyperparathyroidism
- Hyperthyroidism
- Osteoporosis
- Subclinical Hypothyroidism
- Type 2 Diabetes Mellitus
Conditions and procedures
Conditions I treat
- Acromegaly
- Adrenal Crisis
- Adrenal Gland Disorders (E.G. CUSHING'S SYNDROME, PHEOCHROMOCYTOMA)
- Adrenal Tumor
- Adrenogenital Disorders
- Benign Neoplasm Of Digestive System
- Bone Density Disorder
- Cushing Syndrome
- Diabetes Insipidus
- Diabetic Nephropathy
- Diabetic Neuropathy
- Diabetic Retinopathy
- Disorders Of Lipoprotein Metabolism And Lipidemias
- Disorders Of Mineral Metabolism
- Disorders Of Pancreatic Internal Secretion
- Disorders Of Pituitary Gland
- Disorders Of Thyroid
- Drug Or Chemical Induced Diabetes Mellitus
- Endocrine Disorders
- Family History Of Malignant Neoplasm
- Gallbladder Disease
- Gestational Diabetes
- Grave's Disease
- Growth Hormone Deficiency
- Hashimoto Thyroiditis
- High Cholesterol
- Hyperaldosteronism
- Hyperfunction Of Pituitary Gland
- Hyperparathyroidism
- Hyperprolactinemia
- Hyperthyroidism
- Hypertrichosis
- Hypoparathyroidism
- Insulin Resistance
- Long Term Drug Therapy
- Male Hypogonadism
- Malignant Neoplasm Of Endocrine Glands
- Metabolic Syndrome
- Nonscarring Hair Loss
- Nontoxic Goiter
- Obesity
- Orbit Disorders
- Osteochondropathies
- Osteopenia
- Osteoporosis
- Ovarian Dysfunction
- Parathyroid Disorders
- Polycystic Ovary Syndrome
- Polyglandular Dysfunction
- Postprocedural Complications
- Presence Of Functional Implants
- Proteinuria
- Subclinical Hypothyroidism
- Testicular Dysfunction
- Thyroid Cancer
- Thyroid Goiter
- Thyroid Nodules
- Thyroid Storm
- Thyrotoxic Crisis
- Type 2 Diabetes
- Type 2 Diabetes Mellitus
- Vitamin Deficiency
Procedures I perform
- Celiac Plexus Block
- Popliteal Artery Entrapment Syndrome Treatment
Practice locations
Distance from Change Location Enter your Location
5601 Loch Raven Blvd
GHC O'Neill Bldg 2nd Fl
Baltimore, MD, 21239
Insurance
This list represents the major payors accepted by MedStar Health. NOTE: Payor contracts change and not all plans associated with a payor may be covered. Payors may offer multiple plans. If you have a question related to your insurance, please contact your insurance plan directly. Contact information is located on your health insurance ID card. *Denotes limited participation. Specific providers and practices may NOT be participating. Please contact your insurance plan directly.
-
List of insurance plans we accept
- Aetna
- CareFirst BlueCross BlueShield of Maryland
- Cigna Health Care
- Kaiser Permanente*
- MedStar Select (Administered by CareFirst)
- United HealthCare
- Aetna
- CareFirst BlueCross BlueShield of Maryland
- Healthspring
- Humana
- Medicare & Railroad Medicare
- United HealthCare
- Aetna Better Health of Maryland *
- Medical Assistance/Medicaid
- MedStar Family Choice MD
- Priority Partners *
- United HealthCare Community Health Plan MD
- Wellpoint MD
- AmeriHealth Caritas
- Health Services For Children With Special Needs (HSCSN)
- Medical Assistance/Medicaid
- MedStar Family Choice DC
- Johns Hopkins Employer Health Programs *
- Johns Hopkins US Family Health Plan *
- MultiPlan
- Private Healthcare Systems
- Tricare/Humana Military
- VA Community Care Network (VACCN)
Education
Board Certification: American Board of Internal Medicine, Endocrinology, Diabetes and Metabolism
Residency: Rutgers Robert Wood Johnson Medical School (2004)
Medical School: Robert Wood Johnson Medical School (2001)
Hospital affiliations
News and publications
Pittas AG, Dawson-Hughes B, Sheehan P, Ware JH, Knowler WC, Aroda VR, Brodsky I, Ceglia L, Chadha C, Chatterjee R, Desouza C, Dolor R, Foreyt J, Fuss P, Ghazi A, Hsia DS, Johnson KC, Kashyap SR, Kim S, LeBlanc ES, Lewis MR, Liao E, Neff LM, Nelson J, O'Neil P, Park J, Peters A, Phillips LS, Pratley R, Raskin P, Rasouli N, Robbins D, Rosen C, Vickery EM, Staten M; D2d Research Group. Vitamin D Supplementation and Prevention of Type 2 Diabetes. N Engl J Med. 2019 Aug 8;381(6):520-530.
Kuhn, A, Park JY, Ghazi A, Aroda V. Intensifying Treatment Beyond Monotherapy in Type 2 Diabetes Mellitus: Where Do Newer Therapies Fit? Current Cardiology Reports. (2017) 19: 25.
Park JY, Chong AY, Cochran EK, Kleiner DE, Haller MJ, Schatz DA, Gorden P. Type 1 diabetes associated with acquired generalized lipodystrophy and insulin resistance: the effect of long-term leptin therapy. Journal of Clinical Endocrinology and Metabolism, 2008;93(1):26-31.
Guettier JM, Park JY, Cochran EK, Poitou C, Basdevant A, Meier M, Clément K, Magré J, Gorden P. Leptin therapy for partial lipodystrophy linked to a PPAR-gamma mutation. Clinical Endocrinology (Oxf). 2008;68(4):547-54.
Park JY, Javor ED, Cochran EK, DePaoli AM, Gorden P. Long-term efficacy of leptin replacement in patients with Dunnigan-type familial partial lipodystrophy. Metabolism, 2007; 56(4):508-16.
Park JY, Gavrilova O, Gorden P. The clinical utility of leptin therapy in metabolic dysfunction. Minerva Endocrinologica. 2006;31(2):125-31.
Gorden P, Park, JY. The clinical efficacy of the adipocyte-derived hormone leptin in metabolic diseases. Archives of Biochemistry and Physiology, 2006; 112(2):114-8.